Adderall News and Research

RSS
Adderall (dextroamphetamine-amphetamine) is a combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur.
Mice may hold clues in development of ADHD, autism and bipolar disorder

Mice may hold clues in development of ADHD, autism and bipolar disorder

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

10,000 toddlers receive medication for ADHD, shows report

10,000 toddlers receive medication for ADHD, shows report

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Research findings point to potential biomarkers for early detection of at-risk youth

Research findings point to potential biomarkers for early detection of at-risk youth

Research roundup: Medicaid eligibility; tracking discontinued randomized trials; decline in work-based insurance

Research roundup: Medicaid eligibility; tracking discontinued randomized trials; decline in work-based insurance

Viewpoints: 'Middlling news' on enrollment; 'secret mandate exemption;' Obama's surprising appearance between two ferns

Viewpoints: 'Middlling news' on enrollment; 'secret mandate exemption;' Obama's surprising appearance between two ferns

Global initiatives underscore shire's long-term commitment to rare disease community

Global initiatives underscore shire's long-term commitment to rare disease community

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Impax Laboratories records adjusted net loss of $1.6 million in fourth quarter 2013

Shire signs agreement to supply authorized generic version of Adderall XR

Shire signs agreement to supply authorized generic version of Adderall XR

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

First Edition: October 16, 2013

First Edition: October 16, 2013

Shire resolves patent infringement lawsuit against Teva relating to INTUNIV tablet

Shire resolves patent infringement lawsuit against Teva relating to INTUNIV tablet

New U-M poll shows 1 in 100 parents believe their kids use prescription stimulants to boost grades

New U-M poll shows 1 in 100 parents believe their kids use prescription stimulants to boost grades

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Roundup: Battles in five states become central to abortion fight; Calif. prison spending on anti-psychotics raises treatment questions

Roundup: Battles in five states become central to abortion fight; Calif. prison spending on anti-psychotics raises treatment questions

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

1 in 4 teens misused or abused a prescription drug at least once in their lifetime

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD